Ventricular Assist Devices | CMS Coverage Update

Summary: The Centers for Medicare & Medicaid Services modified its Ventricular Assist Devices coverage policy, effective May 15, 2026. Here's what billing teams need to do before that date.

CMS ventricular assist device coverage policy updates don't happen often — but when they do, the financial exposure is significant. Ventricular assist device billing touches some of the highest-cost DRGs in the Medicare system, and a coverage criteria shift can mean the difference between full reimbursement and a six-figure claim denial. The policy document for this update is published at PayerPolicy under the Ventricular Assist Devices entry, with the effective date of May 15, 2026. This article does not list specific codes because the policy document does not publish a specific code set — your billing team should cross-reference your current charge capture against the updated coverage criteria directly.

Quick-Reference Table

CMS Ventricular Assist Device Coverage Criteria and Medical Necessity Requirements 2026

Ventricular assist devices sit at the intersection of advanced heart failure treatment and some of the most complex coverage policy terrain in Medicare. These devices — implantable mechanical pumps that support a failing ventricle — are covered under Medicare as either a bridge to transplant or as destination therapy for patients who aren't transplant candidates. Both pathways carry distinct medical necessity requirements, and that distinction matters enormously for your billing team.

The Centers for Medicare & Medicaid Services historically tied VAD coverage to patient-level criteria: documented end-stage heart failure, specific ejection fraction thresholds, failure of optimal medical therapy, and multidisciplinary team evaluation. Whether the May 15, 2026 modification tightens, expands, or clarifies those criteria is what your billing and clinical teams need to confirm against the full policy text before the effective date.

This is not a policy where you can afford to wait and see. VAD procedures routinely generate claims in the $150,000–$300,000 range when you factor in device cost, implant surgery, and post-operative management. A single claim denial tied to documentation that doesn't satisfy updated medical necessity standards is a painful recovery.

Prior authorization requirements for VADs under Medicare are typically handled at the Medicare Administrative Contractor level. That means your MAC may have a Local Coverage Determination that layers additional requirements on top of the national policy. Check both the updated CMS national coverage policy and your MAC's active LCD before May 15, 2026.

If you're running an advanced heart failure program that bills for both bridge-to-transplant and destination therapy indications, assign someone to do a line-by-line read of the updated policy now. Don't delegate this to a general coding review — the clinical nuance here requires your cardiac billing specialist and your compliance officer working together.

CMS Ventricular Assist Device Exclusions and Non-Covered Indications

Medicare does not cover VADs outside of specific, documented indications. The coverage policy has historically excluded temporary external ventricular support devices used solely for short-term hemodynamic stabilization when that use doesn't meet the threshold for implantable device coverage criteria.

Patients who don't meet the heart failure severity thresholds — or whose clinical documentation doesn't adequately capture that severity — are at high risk for claim denial. The real issue here is documentation quality, not clinical eligibility. Most VAD patients who get denied actually qualified clinically. The record just didn't say so in the language the coverage policy requires.

Investigational indications remain excluded. If your program is running a clinical trial that includes VAD implantation for indications outside the approved coverage criteria, those claims route differently — typically through clinical trial billing protocols, not standard Part A or Part B claim pathways.

Watch for any modifications in this update that redefine the boundary between "bridge to transplant" and "destination therapy." If CMS tightens who qualifies for each pathway, programs that have been billing one way may need to reassess their documentation templates immediately.

Coverage Indications at a Glance

Because the policy document for this May 2026 update does not publish a specific indication-by-indication breakdown in the data available at time of writing, the table below reflects the standard CMS VAD coverage framework. Verify each row against the full policy text before May 15, 2026.

CMS Ventricular Assist Device Billing Guidelines and Action Items 2026

Here's what your team needs to do before May 15, 2026.

CPT, HCPCS, and ICD-10 Codes for Ventricular Assist Devices Under This CMS Policy Update

The policy document for this update does not publish a specific list of CPT, HCPCS, or ICD-10 codes. This is not unusual for CMS national policy modifications — code-level detail is often embedded in associated LCD documents, NCCI edits, or MAC-specific billing guidance rather than the national coverage policy itself.

Do not attempt to construct a code list from memory or from older policy versions. Code sets for VAD billing shift as device technology evolves and new HCPCS codes are established for new device models.

How to Get the Right Code List

Contact your MAC directly and request the current covered code list for ventricular assist devices under the updated national coverage criteria. Cross-reference that against your charge master. If your program bills through a hospital outpatient or inpatient DRG pathway, confirm with your hospital coding team that the DRG assignment logic still holds under the updated criteria.

Your billing consultant or revenue cycle vendor should also be able to pull the current HCPCS codes associated with VAD devices — these are device-specific and change as CMS assigns new codes to newly approved devices. Don't assume your current code set is complete.

If you're a smaller practice or a cardiology group that refers into a hospital program for implants but manages post-acute VAD care, confirm with the hospital billing team which codes they're using and how the split-billing arrangement works under the updated coverage policy.